Prostate Cancer - Results from #26120

Patient knowledge about prostate-specific antigen (PSA) and prostate cancer in Australia - Abstract May 28, 2012

Assessing the risk of lymph node invasion in patients with intermediate risk prostate cancer treated with extended pelvic lymph node dissection. A novel prediction tool - Abstract May 25, 2012

RNASEL study of genetics of prostate cancer and its relation to clinical staging - Abstract May 25, 2012

3.0 T multiparametric prostate MRI using pelvic phased-array coil: Utility for tumor detection prior to biopsy - Abstract May 25, 2012

MRI in addition to or as a substitute for prostate biopsy: The clinician's point of view - Abstract May 25, 2012

Clinical significance of free-to-total prostate-specific antigen (PSA) ratio in advanced prostate cancer patients with PSA less than 0.1 ng/ml after hormone treatment - Abstract May 25, 2012

Algorithm for selecting men for pelvic lymph node dissection (PLND) during radical prostatectomy based on clinical risk factors in an Australian population - Abstract May 25, 2012

Advanced prostate cancer: Treatment and patient-centred care - Abstract May 25, 2012

Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy - Abstract May 25, 2012

ACR Appropriateness Criteria® external-beam radiation therapy treatment planning for clinically localized prostate cancer - Abstract May 25, 2012

Prostate weight is the preferred measure of prostate size in radical prostatectomy cohorts - Abstract May 25, 2012

Active surveillance for prostate cancer: An Australian experience - Abstract May 25, 2012

In situ and intraductal epithelial proliferations of prostate: Definitions and treatment implications. Part 1: Prostatic intraepithelial neoplasia - Abstract May 25, 2012

Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI - Abstract May 25, 2012

Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer - Abstract May 25, 2012

Detecting prostate cancer with MRI - why and how - Abstract May 25, 2012

Endocrine prevention and treatment of prostate cancer - Abstract May 25, 2012

Imaging techniques for local recurrence of prostate cancer: For whom, why and how? - Abstract May 25, 2012

Phase I/II trial of single-fraction high-dose-rate brachytherapy-boosted hypofractionated intensity-modulated radiation therapy for localized adenocarcinoma of the prostate - Abstract May 25, 2012

AUA 2012 - The association between male pattern baldness and second to fourth finger ratio with prostate cancer - a prospective cohort study - Press Briefing May 24, 2012

Page 1307 of 1453